INTERNATIONAL STRATEGIC HEALTHCARE COMMUNICATIONS

Experienced, trusted advisors to some of the world's most exciting public and private companies across pharmaceuticals, medtech, digital health, biotech and healthcare services, large & small.

WHAT WE DO

COMMUNICATING A COMPELLING GROWTH STORY TO THE INVESTMENT COMMUNITY

Effectively communicating a company’s strategy, growth ambitions, and the reasons to “invest now” is critical for management teams as they seek to build investor confidence and support. We have an exceptional track record in advising globally on healthcare fund raisings, IPOs and M&A transactions.

FIND OUT MORE

Insights & Latest News

Our November newsletter has just landed! See here: https://bit.ly/2Jb1M1Z

In this edition, we share views on Investor Relations from @Dan_Mahony and @KieranMurphyCEO @MaryClarkOpt Kevin Mannix @tevapharm and Oliver Maier @BayerPharma #investors #healthcare #Pharmaceutical

Destiny Pharma announces that it has conditionally raised total gross proceeds of approximately £0.87m through the Open Offer which was announced on 9 Nov 2020. This is in addition to the £9.5m raised in the placing to support the acquisition of NTCD-M3.

https://bit.ly/DP25112020-1

Optimum's 12th Annual

Healthcare Investor Conference

8th October 2020 | LONDON VIRTUAL

More info

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH